In HCC, NBR2 attenuates Beclin1-induced cytoprotective autophagy to inhibit cancer proliferation through the extracellular regulated protein kinase (ERK) and c-Jun N-terminal kinase (JNK) pathways, which provides novel insights on a treatment strategy for HCC (95, 96). Here, MAPK8 is linked to hepatocellular carcinoma.